RH
Insider
R David Hoover
DirectorR David Hoover (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Elanco Animal Health Incorporated (ELAN). Across 1 priced purchase filing, the average 21-session return was -0.5% from execution and -15.0% from disclosure (delay-adjusted; derived). The largest single filing was $272K of ELAN (25,000 sh × $10.90, as filed), executed Mar 5 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-0.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-15.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$272K
shares × price, as filed
Last traded
Mar 5 2025
Filed Mar 7 2025
Median ADV $140.0M across their filed names
Open performance→Volume by month
Buys $272K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ELANRecent filings
ELANPURCHASE
Elanco Animal Health Incorporated
View filing →
$272K25,000 sh × $10.90
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET